Deborah Fuller, John Farrow, Lebron James discussed on Bloomberg Surveillance

Automatic TRANSCRIPT

The Exchequer Ricci soon Act Francine Lacqua catching up with him a couple of hours ago, Really emphasizing to support this economy will still need And the idea that really to recover. We need to reopen and do it carefully from New York City this morning. Good morning to you all along side. Some came together with Lisa Kravitz. I'm Jonathan Farrow. With equity futures totally unchanged in the S and P 500. We were negative a cup of Africa around 4 a.m. Eastern recovered into positive territory. We roll over. Around about a single point. In the last couple of minutes. In the bond market elsewhere, Treasury was coming to basis points to 0.67% on its senior years. Come in just a little bit. The curves slightly fat, flatter and foreign exchange really muted price action time. We keep saying it feels like any other Friday in this market, but we know for this country it is anything but Just another Friday. It is the oddest thing John to see the quiet in the market today and is talking to Kevin so really, just the extraordinary angst in this nation about the pandemic. Yesterday, folks who spent a lot of time looking at a basketball star and most you know the name LeBron James. What if you are able to talk to the LeBron James of the vaccine racket? We talked to the great Peter Hotez of Baylor. We talked to Steven Riley over Imperial College. Deborah Fuller owns the high ground at the University of Washington. And let me tell you recent images of her labs are simple. They looked like a war zone. It is a war to find a vaccine. Debra Fuller joins us in her early morning from the University of Washington. Dr Fuller. How close are you? To the vaccine that we all desperately need. Right? Well, my laboratory is currently in pre clinical studies for AH, candidate back scene and what That means that we're still testing it in animal models and haven't quite moved yet in human clinical trials. Tell us about that transfer and folks we need to say this because Dr Fuller, of course, leads the Washington National Primate Research Center. What are the risks as you move from primates over the testing on John Farrow? Yeah, the really, you know, risk are you know in the in the first initial testing in humans, it's really a phase one clinical trial and that is really done to test taking humans. Prior to reaching that point, we will have tested safety and in animals, including non human primates, and that includes things like toxicity reacted to necessity. Three ability of the vaccines to protect that animal from an infection and so have ah, what their amount of confidence at the time that we transition into humans that you know we've done everything we can you know, at that point in pre clinical Daddy's Teo to ensure success, particularly in the safety, if not also the efficacy of the vaccine. Doctor. I appreciate how seriously you answered that question. That's my colleague, Tom. Just trying a little bit of shade. It may comparing me to an animal doctors. We can keep it serious and think about the spread of this virus. Quite clearly, We have some fragility in places like Texas. What do they need to do now is pausing the re opening process. Enough to see this day to improve in the coming weeks and months. Yeah, you know, So you know, until we have a vaccine, which is really the most effective way to control pandemic, the measures that you know a number of groups are taking and such is where mass social distancing and the like, are still going to be very important as well as scaling up the testing. Because if you can identify where the virus is, who is infected that could help you know, communities control that infection much better so Really still in that domain of needing better testing and eating to maintain our social distancing and wearing mask, So you know viruses they just transmit. That's what they do in a song as there is a warm body for them to, In fact, they will find a way to infect that. So you know, until we have immunity built in the population we're still going to see And, you know, putting upticks of virus transmission and, you know, increased spread of the virus. You know a song that you know out there without that thing. Dr Fuller. You put it really well, this idea that we're basically buying time ahead of some sort of collective herd immunity that can really only be had either with massive deaths, catastrophic deaths or a vaccine and a lot of a slowdown in an economy with respect to getting a vaccine as early as thiss year, possibly early next year. How concerned are you about the safety of it, let alone the efficacy, but just the idea that it hasn't necessarily been tested over a longer term period. Yeah. Traditionally, vaccines have you know, taking their stepwise approach where you go to three phases of human clinical trial. The first phase, which we talked about already is just to make sure that it's safe. And that's usually a smaller number of people. And, you know, actually all phases of a clinical trial all the way through the second and third constantly, Cassie for safety, you know various boxes that have to be checked before they can move on to the next one. In a second phase that goes into a larger number of people, including, you know, people will be more vulnerable that Eugene comprised of people typically don't respond well to that seems such as the elderly and then in phase three year really testing ethically you're going Tio administer the vaccine could be tens of thousands of people Onda placebo to another tens of thousands of people, then comparing the two populations..

Coming up next